Abstract
A series of 3-diarylethyne quinazolinone compounds (4a–ad) were synthesized and evaluated for their cytotoxicity. They exhibited significant anticancer activity against MDA-MB-231, A549, MIAPaCa-2 and Colo-205 cancer cell lines and were highly effective in the MCF-7 cancer cell line with IC50 values ranging from 2.27 to 3.88 μM. FACS analyses and BrdU assays revealed that there is G1 cell cycle arrest. Moreover, cells treated with these compounds show up-regulation of p53, p21, p16, TRF1 and POT1 and down-regulation of SKP2, TRF2 and tankyrase protein levels. To assess the senescence inducing ability of these compounds further, a senescence associated β-gal assay was performed. Interestingly, two of these compounds (4s and 4w) exhibited significant telomerase inhibition activity and inhibited tankyrase-1 protein, a protein partner associated with the sheltrin complexes of telomeres.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
